No Data
No Data
No Data
No Data
No Data
Express News | Vistagen Therapeutics Inc: Ph15 Was Safe and Well-Tolerated With an Adverse Event Profile Similar to Placebo
ReutersApr 25 08:30 ET
Express News | Vistagen Therapeutics Inc: Ph15 Nasal Spray Demonstrates Statistically Significant Efficacy Versus Placebo and Caffeine
ReutersApr 25 08:30 ET
Express News | Vistagen Announces Positive Results From Phase 2a Pilot Study of Ph15 for Improvement of Psychomotor Impairment Caused by Mental Fatigue
ReutersApr 25 08:30 ET
Vistagen to Present at the 2024 Anxiety and Depression Association (ADAA) Conference
Vistagen (NASDAQ:VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today announced
BusinesswireApr 9 08:30 ET
30 Countries With the Lowest Depression Rates
Yahoo FinanceMar 26 06:24 ET
This Overlooked Corner of Women's Health Could Be a $350 Billion Market Opportunity
Menopause is among the female health conditions with the highest unmet need and has 'enormous potential for innovative treatments,' according to McKinsey.
CNBCMar 15 14:33 ET
No Data
No Data
多買多賺買少少虧金牛 : How high chance flying?
TrytosaveabitOP 多買多賺買少少虧金牛: Not sure! Gotta see what volume/interest it gets?
多買多賺買少少虧金牛 TrytosaveabitOP: strange movement dropping
TrytosaveabitOP 多買多賺買少少虧金牛: No volume
多買多賺買少少虧金牛 : Is the vol 54mil on 7Aug23 real? Total issue shares only 27mil